Skip to main content
editorial
. 2015 Jul 4;6(24):19960–19961. doi: 10.18632/oncotarget.4758

Figure 1. NK cell optimal in vivo activity requires type I and III IFN receptors.

Figure 1

Antigen-presenting cells (APC) and mononuclear phagocytes produce cytokines such as IFN type I and III, which prime NK cells and enhance their effector function for enhanced cytotoxic killing and cytokine production.